Evidence map›Paper›PMID 33951478›Full record

ArticleCell stem cell2021

Activation of HERV-K(HML-2) disrupts cortical patterning and neuronal differentiation by increasing NTRK3.

Vidya Padmanabhan Nair, Hengyuan Liu, Gabriele Ciceri, Johannes Jungverdorben, Goar Frishman, Jason Tchieu, Gustav Y Cederquist, Ina Rothenaigner, Kenji Schorpp, Lena Klepper and 9 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Cell stem cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
8.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. The evaluation of human endogenous retroviral env expression in normal and cancerous tissues of the breast.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Vidya Padmanabhan NairInstitute of Virology, Helmholtz Zentrum München, Neuherberg, Germany.
Hengyuan LiuDepartment of Genome-Oriented Bioinformatics, Technical University Munich, Munich, Germany.
Gabriele CiceriDevelopmental Biology and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Johannes JungverdorbenDevelopmental Biology and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Goar FrishmanInstitute of Experimental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Jason TchieuDevelopmental Biology and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Gustav Y CederquistDevelopmental Biology and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ina RothenaignerAssay Development and Screening Platform, Helmholtz Zentrum München, Neuherberg, Germany.
Kenji SchorppAssay Development and Screening Platform, Helmholtz Zentrum München, Neuherberg, Germany.
Lena KlepperInstitute of Virology, Helmholtz Zentrum München, Neuherberg, Germany.
Ryan M WalshDevelopmental Biology and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Tae Wan KimDevelopmental Biology and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Daniela CornacchiaDevelopmental Biology and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Andreas RueppInstitute of Experimental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Jens MayerInstitute of Human Genetics, University of Saarland, Homburg, Germany.
Kamyar HadianAssay Development and Screening Platform, Helmholtz Zentrum München, Neuherberg, Germany.
Dmitrij FrishmanDepartment of Genome-Oriented Bioinformatics, Technical University Munich, Munich, Germany.
Lorenz StuderDevelopmental Biology and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Michelle VincendeauInstitute of Virology, Helmholtz Zentrum München, Neuherberg, Germany; Developmental Biology and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: michelle.vincendeau@helmholtz-muenchen.de.
Memorial Sloan Kettering Cancer Center · USHelmholtz Zentrum München · DETechnical University of Munich · DESaarland University · DE

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Novel strategies for induction of aging in human PSC-derived lineages for modeling Alzheimer's DiseaseR01AG054720 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI Doron Betel, LORENZ P. STUDER · 2017 to 2026
$4.5M
NCI NIH HHS P30 CA008748NIA NIH HHS R01 AG054720
6 · The paper itself

Abstract

The biological function and disease association of human endogenous retroviruses (HERVs) are largely elusive. HERV-K(HML-2) has been associated with neurotoxicity, but there is no clear understanding of its role or mechanistic basis. We addressed the physiological functions of HERV-K(HML-2) in neuronal differentiation using CRISPR engineering to activate or repress its expression levels in a human-pluripotent-stem-cell-based system. We found that elevated HERV-K(HML-2) transcription is detrimental for the development and function of cortical neurons. These effects are cell-type-specific, as dopaminergic neurons are unaffected. Moreover, high HERV-K(HML-2) transcription alters cortical layer formation in forebrain organoids. HERV-K(HML-2) transcriptional activation leads to hyperactivation of NTRK3 expression and other neurodegeneration-related genes. Direct activation of NTRK3 phenotypically resembles HERV-K(HML-2) induction, and reducing NTRK3 levels in context of HERV-K(HML-2) induction restores cortical neuron differentiation. Hence, these findings unravel a cell-type-specific role for HERV-K(HML-2) in cortical neuron development.

Indexed as

Endogenous RetrovirusesCell DifferentiationHumansTranscriptional ActivationCRISPRendogenous retrovirusforebrain orgnoidHERVinfluencing cortical neuronal developmentNeurotrophic Tyrosine Receptor Kinase 3NTRK3retrotransposon

Identifiers

PMID33951478
PMCPMC8419085
OpenAlexW3157549151

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.